Bharadhwaj ‘Bharat’ Ramamoorthy takes charge at BGG Europe and International Division amid global growth plans

PRESS RELEASE

Bharadhwaj ‘Bharat’ Ramamoorthy has been associated with BGG since 2023 (photo credit: BGG)

BGG Group has named Bharadhwaj ‘Bharat’ Ramamoorthy as the new CEO of BGG Europe and Head of the International Division. He succeeds Jürgen Nelis, who steps into the role of Chairman of the BGG Europe board.

Founded in China in 1995, BGG is a global leader in astaxanthin and supplies a wide range of natural ingredients for supplements, pharmaceuticals, cosmetics, personal care, and food and drink.

Bharat has been associated with BGG since 2023 and became a company director in 2025 to drive strategy. He now takes charge of BGG’s operations outside China and Japan as it steps up its growth plans worldwide.

Bharat said: “I’m delighted to have the opportunity to steer BGG into an exciting new era. I am deeply aligned with BGG’s values and ambitions, and I now look forward to accelerating our expansion across the globe.”

Bharat has extensive leadership, strategic, finance, and merger and acquisition experience from his time with flavor and fragrance multinational Givaudan as well as serving as a director with the Keva group in Europe.

He takes over from Jürgen Nelis, who led the launch of BGG’s European headquarters in Switzerland in 2024 and has overseen the expansion of the company’s teams and operations in Europe and the United States to support its growing international customer base.

As BGG Europe Chairman, Jürgen will work with Bharat to support the transition of executive responsibilities before focusing on new projects to facilitate additional expansion plans.

Mr Chunhua Li, the founder and principal shareholder of BGG, said: “We would like to sincerely thank Jürgen for his outstanding contributions to the performance, growth, and development of the BGG Group. Through his leadership, commitment, and strategic guidance, he has played an important role in strengthening the organization and supporting its continued success. We also congratulate Bharat on assuming these responsibilities and wish him every success in his expanded leadership role.”

BGG’s capabilities and expertise extend to microalgae, enzymatic and botanical extractions to promote healthy long life in humans. Its portfolio includes AstaZine® astaxanthin, TheraPrimE® tocotrienols, ThinOgen® fucoxanthin, ApplePhenon® apple extract, and Vitosa® stevia as well as licorice extracts for cosmetics, personal care, and food.

About BGG

BGG is a global specialty provider of science-backed natural ingredients for supplements, pharmaceuticals, cosmetics, personal care, and food and drink.

Founded in 1995, the company is the world’s largest producer of natural astaxanthin and a recognized leader in microalgae solutions. The BGG portfolio features a vast array of, marine, fruit and herbal extracts and compounds including:

  • AstaZine® astaxanthin
  • TheraPrimE® tocotrienols
  • ThinOgen® fucoxanthin
  • ApplePhenon® apple extract
  • Vitosa® next-generation stevia
  • Licorice extracts

From cultivation to formulation, BGG’s global operations ensure secure, scalable supply with a responsible approach to the environment. All ingredients undergo rigorous quality control and safety tests, with standardization assured and product claims backed by transparent data.

BGG is committed to long-term partnerships, helping brands differentiate with high-purity ingredients that deliver proven performance and build consumer trust.

Visit bggworld.com for more information.

Bharat Ramamoorthy (photo credit: BGG).jpg

JPEG 898 KB

BGG aerial image (photo credit: BGG).jpeg

JPEG 801 KB

Press release - Ramamoorthy takes charge at BGG Europe and International Division.docx

DOCX 84 KB

Press release - Ramamoorthy takes charge at BGG Europe and International Division.pdf

PDF 256 KB

 

 

Share

Latest stories

Website preview
Website preview
Website preview

Get updates in your mailbox

By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.